The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis

Gastrointestinal Endoscopy

Volumn 59, Issue 2, 2004, Pages 179-184

  Schwartz, Jeremy J ^a   Lew, Ronald J ^a   Ahmad, Nuzhat A ^a   Shah, Janak N ^a   Ginsberg, Gregory G ^a   Kochman, Michael L ^a   Brensinger, Colleen M ^a   Long, William B ^a,b  

^a Ravdin Bldg ^*

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; LIDOCAINE; PLACEBO;

ACUTE PANCREATITIS; ADULT; AEROSOL; ARTICLE; CANNULATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; INTESTINE MUCOSA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; VATER PAPILLA; VATER PAPILLA STENOSIS;

ADMINISTRATION, TOPICAL; AMPULLA OF VATER; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLECYSTOKININ; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; PANCREATITIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 1042301318     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5107(03)02540-9     Document Type: Article

References (17)

1. Gottlieb K, Sherman S. ERCP and endoscopic biliary sphincterotomy-induced pancreatitis. Gastrointest Endosc Clin N Am 1998;8:87-114.
2. Tarnasky P, Cunningham J, Cotton P, Hoffman B, Palesch Y, Freeman T, et al. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy 1997;29:252-7.
3. Johnson GK, Geenen JE, Johanson JF, Sherman S, Hogan WT, Cass O. Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media. Gastrointest Endosc 1997;46:217-22.
4. Sherman S, Hawes RH, Rathgaber SW, Uzer MF, Smith MT, Khusro QE, et al. Post-ERCP pancreatitis: randomized prospective study comparing a low- and high-osmolality contrast agent. Gastrointest Endosc 1994;40:422-7.
5. Weiner GR, Geenen JE, Hogan WJ, Catalano MF. Use of corticosteroids in the prevention of post-ERCP pancreatitis. Gastrointest Endosc 1995;42:579-83.
6. De Palma GD, Catanzano C. Use of corticosteroids in the prevention of post-ERCP pancreatitis: results of a controlled prospective study. Am J Gastroenterol 1999;94:982-5.
7. Andriulli A, Leandro G, Niro G, Mangia A, Festa V, Gambassi G, et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc 2000;51:1-7.
8. Poon RTP, Yeung C, Lo CM, Yuen WK, Liu CL, Fan ST. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc 1999;49:593-8.
9. Haber GB. Prevention of post-ERCP pancreatitis. Gastrointest Endosc 2000;51:100-3.
10. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariani A, Di Francesco V. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Eng J Med 1996;335:919-23.
11. Tittobello A. Diagnosis and prevention of post-ERCP pancreatitis. Endoscopy 1997;29:285-7.
12. Miah AR, Bank S, Stark B, Visvalingum V, Tiscornia O. The effect of local lidocaine on the ampler pressures, ease of cannulation and post-ERCP hyperamylasemia and pancreatitis [abstract]. Gastroenterology 2000;118:A162.
13. Karlstrom L, Cassuto J, Jodal M, Lundgren O. The importance of the enteric nervous system for the bile-salt-induced secretion in the small intestine of the rat. Scand J Gastroenterol 1983;18:117-23.
14. Louie DS, May D, Miller P, Owyang C. Cholecystokinin mediates feedback regulation of pancreatic enzyme secretion in rats. Am J Physiol 1986;250:G252-G259.
15. Editorial Staff. General management of local anesthetics (management/treatment protocol). In: Toll LL, Hurlbut KM, editors. POISONDEX(r) system. Englewood (CO): MICROMEDEX; 2002. (edition expires September 2000).
16. Cotton PB, Lehman G, Vennes JA, Geenen JE, Russell RCG, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991;37:383-91.
17. McFarland RJ, Corbett CRR, Taylor P, Nash AG. The relaxant action of hymecromone and lignocaine on induced spasm of the bile duct sphincter. Br J Clin Pharmacol 1984;17:766-8.